Exclusive: BioAdvance portfolio generated $450M in fiscal 2014

BioAdvance’s portfolio companies brought in $450 million into the region in private investments and sale proceeds during its soon-to-end current fiscal year, the highest mark ever for the operator of the Biotechnology Greenhouse of southeastern Pennsylvania...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.